Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003492987 | SCV004234299 | uncertain significance | Singleton-Merten syndrome 2 | 2023-02-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003732602 | SCV004533033 | uncertain significance | not provided | 2023-01-07 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DDX58 protein function. This variant has not been reported in the literature in individuals affected with DDX58-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.009%). This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 293 of the DDX58 protein (p.Val293Leu). |